GBI Research Reports
GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.
Search GBI Research Reports
Latest Reports from GBI Research Reports
| |||||||||||||||||||||||
| Name | Date | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market | May 01, 2016 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to #### Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Report Code: GBIHC###MR Published: May #### www.gbiresearch.com © GBI Research. This is a... | |||||||||||||||||||||||
| Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth | May 01, 2016 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Global Dermatology Market to #### Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth Report Code: GBIHC###MR Published: May #### www.gbiresearch.com © GBI Research. This is a licensed product and is... | |||||||||||||||||||||||
| Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market | Apr 21, 2016 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Global Hematological Cancers Market to #### Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market Report Code: GBIHC###MR Published: April #### www.gbiresearch.com © GBI Research. This is a licensed product and is not to be... | |||||||||||||||||||||||
| Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics | Apr 05, 2016 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Global Viral Infections Market to #### Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics Report Code: GBIHC###MR Published: April #### www.gbiresearch.com © GBI Research. This is a licensed product and is not... | |||||||||||||||||||||||
| Global Non-Hematological Cancers Market to 2021 - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics | Apr 01, 2016 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Global Non-Hematological Cancers Market to #### - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics Report Code: GBIHC###MR Published: April #### www.gbiresearch.com © GBI Research. This is a licensed product and... | |||||||||||||||||||||||
| Frontier Pharma: Schizophrenia and Associated Indications - Small but Diverse Range of First-in-Class Molecular Targets Hold Promise for Treatment of Negative and Cognitive Symptoms | Apr 01, 2016 | ||||||||||||||||||||||
| ...FRONTIER PHARMA Schizophrenia and Associated Indications - Small but Diverse Range of First-in-Class Molecular Targets Hold Promise for Treatment of Negative and Cognitive Symptoms Published: April #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed... | |||||||||||||||||||||||
| Frontier Pharma: Gastric Cancer - Early Stage Pipeline Innovation Shows Shift Towards Targeted mAbs | Mar 10, 2016 | ||||||||||||||||||||||
| ...FRONTIER PHARMA Gastric Cancer - Early Stage Pipeline Innovation Shows Shift Towards Targeted mAbs Published: March #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied [Reference: Department of Clinical Pathomorphology... | |||||||||||||||||||||||
| Alzheimers Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Disease Modifying Therapies | Mar 01, 2016 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Alzheimer s Therapeutics in Asia-Pacific Markets to #### - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Disease Modifying Therapies Report Code: GBIHC###MR Published: March #### www.gbiresearch.com © GBI Research. This is a licensed... | |||||||||||||||||||||||
| Asthma Therapeutics in Asia-Pacific Markets to 2021 - High Prevalence and Launch of Late-Stage Biologics will Drive the Market in Spite of Affordability Concerns | Mar 01, 2016 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Asthma Therapeutics in Asia-Pacific Markets to #### High Prevalence and Launch of Late-Stage Biologics will Drive the Market in Spite of Affordability Concerns Report Code: GBIHC###MR Published: March #### www.gbiresearch.com © GBI Research. This is... | |||||||||||||||||||||||
| Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes | Feb 16, 2016 | ||||||||||||||||||||||
| ...FRONTIER PHARMA Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes Published: February #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied [Front cover image reference... | |||||||||||||||||||||||
| Parkinsons Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments | Feb 11, 2016 | ||||||||||||||||||||||
| ...Parkinson s Disease Therapeutics in Major Developed Markets to ####: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long- Acting Symptomatic Treatments Published: February #### Report Code: GBIHC###MR www.gbiresearch.com THERAPY ANALYSIS © GBI Research... | |||||||||||||||||||||||
| Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence | Feb 04, 2016 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Breast Cancer Therapeutics in Asia-Pacific Markets to #### Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence Report Code: GBIHC###MR Published: February #### www.gbiresearch.com © GBI Research. This is a licensed product and... | |||||||||||||||||||||||
| Alzheimers Disease Therapeutics in Major Developed Markets to 2021 - Aging Population and Improved Disease Understanding Increase Demand for Disease Modifying Agents | Feb 01, 2016 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Alzheimer s Disease Therapeutics in Major Developed Markets to #### - Aging Population and Improved Disease Understanding Increase Demand for Disease Modifying Agents Report Code: GBIHC###MR Published: February #### www.gbiresearch.com © GBI Research. This is a licensed product... | |||||||||||||||||||||||
| Frontier Pharma: Parkinsons Disease - Identifying and Commercializing First-in-Class Innovation | Jan 01, 2016 | ||||||||||||||||||||||
| ...FRONTIER PHARMA Parkinson s Disease - Identifying and Commercializing First-in- Class Innovation Published: January #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied [Front cover image courtesy of Dr... | |||||||||||||||||||||||
| Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth | Jan 01, 2016 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Type # Diabetes Mellitus Therapeutics in Asia- Pacific Markets to #### - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth Report Code: GBIHC###MR Published: January #### www.gbiresearch.com © GBI Research. This is a... | |||||||||||||||||||||||
| Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation | Dec 16, 2015 | ||||||||||||||||||||||
| ...FRONTIER PHARMA Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation Published: December #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published DEC ####... | |||||||||||||||||||||||
| Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence | Dec 15, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Breast Cancer Therapeutics in Major Developed Markets to #### - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence Report Code: GBIHC###MR Published: December #### www.gbiresearch.com © GBI Research. This is a licensed product and... | |||||||||||||||||||||||
| Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth | Dec 01, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Global Immunology Market to #### - Large pipeline and competitive market to drive long- term market growth Report Code: GBIHC###MR Published: December #### www.gbiresearch.com © GBI Research. This product must only be used under the terms of license... | |||||||||||||||||||||||
| Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape | Dec 01, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Pancreatic Cancer Therapeutics in Major Developed Markets to #### - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape Report Code: GBIHC###MR Published: December #### www.gbiresearch.com © GBI Research. This is a licensed product and is... | |||||||||||||||||||||||
| Frontier Pharma: Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation | Dec 01, 2015 | ||||||||||||||||||||||
| ...FRONTIER PHARMA Ovarian Cancer - Identifying and Commercializing First-in- Class Innovation Published: December #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published DEC #### Page # #... | |||||||||||||||||||||||
